The TKF1000 at TWI in Cambridge��. Source: Titomic
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Titomic (TTT) finalises installation of a Titomic TKF1000 cold spray system at leading technology and research organisation, TWI UK
  • The company says it will recognise revenue from the sale and installation of £1.2 billion (A$2.2 million), which will be reflected in Titomic’s FY22 figures
  • The purchase of the TKF1000 will help TWI and its industrial members complete a portfolio of projects under the umbrella of the cold spray additive manufacturing project, due to be completed by the end of 2022
  • Titomic Managing Director Herbert Koeck says the partnership with TWI furthers the company’s credentials in the aerospace sector
  • Shares in Titomic are up 15.2 per cent, trading at 26.5 cents as of 12:21 pm AEST

Titomic (TTT) has finalised installation of a Titomic TKF1000 cold spray system at leading technology and research organisation, TWI UK.

The company said it will recognise revenue from the sale and installation of £1.2 billion (A$2.2 million) and this amount will be reflected in Titomic’s FY22 figures.

The TKF1000 will play a key role in the Aerospace Technology Institute (ATI) programme,
a £3.9 billion joint government and industry initiative to offer funding for research and
technology development in the UK which will help maintain and grow the country’s competitive position in civil aerospace.

The purchase of the TKF1000 will help TWI and its industrial members complete a portfolio of projects under the umbrella of the cold spray additive manufacturing project, due to be completed by the end of 2022.

Titomic Managing Director Herbert Koeck said the partnership with TWI furthers the company’s credentials in the aerospace sector.

“The UK government is awarding grants to technology that helps improve its aerospace manufacturing, so the capabilities of the TKF1000 have been validated through it being a part of the ATI programme,” he said.

“TWI will be able to unlock new possibilities with the TKF1000 and to see further advancements of aerospace technology.”

Further, Titomic expects the sale might lead to further machine sales in the future for commercial applications and will also offer metal powder consumables sales, in addition to ongoing technical support and expertise.

TWI Section Manager Dr Henry Begg said the TKF1000 system complements its exisiting facilities for laser, arc and electron beam additive manufacture.

“Having been active in cold spray research for the past 15 years, we will now be able to perform larger and more complex fabrications and, working closely with Titomic and our wide industrial membership base, develop the potentially revolutionary opportunities this technology brings.”

Shares in Titomic were up 15.2 per cent, trading at 26.5 cents as of 12:21 pm AEST.

TTT by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Worst session in 6 weeks for bourse | July 25, 2024

The ASX200 closed in the red, down nearly 1.3% to 7,861.2 points. All sectors made losses…
The Market Online Video

ASX Market Update: Index falls hard on company earnings | July 25, 2024

The ASX200 has been trading down nearly 1.2% to 7,870 points. Overnight, earnings reports from US…
Saccharomyces cerevisiae yeast, 3D illustration.

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Biotech company Tissue Repair Ltd (ASX:TRP) has seen its share price rise more than 30% on news it had gained TGA (Therapeutic
Closeup graph of Binary option for trading platform

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Tech sector companies Ovanti Ltd and Brainchip Holdings Ltd joined Lake Resources Ltd and VHM Ltd…